PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol.

about

PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol.

Item

http://www.wikidata.org/entity/Q55233411

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

PROstate Multicentre External ...... the PROMETHEUS study protocol.

@en

PROstate Multicentre External ...... the PROMETHEUS study protocol.

@nl

type

Item

label

PROstate Multicentre External ...... the PROMETHEUS study protocol.

@en

PROstate Multicentre External ...... the PROMETHEUS study protocol.

@nl

prefLabel

PROstate Multicentre External ...... the PROMETHEUS study protocol.

@en

PROstate Multicentre External ...... the PROMETHEUS study protocol.

@nl

P1476

PROstate Multicentre External ...... the PROMETHEUS study protocol.

@en

P2093

David Pryor

http://www.w3.org/2001/XMLSchema#string

Jarad M Martin

http://www.w3.org/2001/XMLSchema#string

Joseph Bucci

http://www.w3.org/2001/XMLSchema#string

Lee Wilton

http://www.w3.org/2001/XMLSchema#string

Mark Sidhom

http://www.w3.org/2001/XMLSchema#string

Matthew Richardson

http://www.w3.org/2001/XMLSchema#string

Mel Grand

http://www.w3.org/2001/XMLSchema#string

Sankar Arumugam

http://www.w3.org/2001/XMLSchema#string

Sarah Gallagher

http://www.w3.org/2001/XMLSchema#string

Sarah Keats

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose conformal radiotherapy reduces prostate cancer-specific mortality: results of a meta-analysis.

Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics

Relationship of imaging frequency and planning margin to account for intrafraction prostate motion: analysis based on real-time monitoring data.

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Brachytherapy: where has it gone?

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2010 consensus guidelines for definitive external beam radiotherapy for prostate carcinoma.

Clinician's guide to prostate IMRT plan assessment and optimisation.

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam B

P2888

s12885-018-4511-6

P304

588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4511-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1104168494

http://www.w3.org/2001/XMLSchema#string

P698

29793444

http://www.w3.org/2001/XMLSchema#string

P932

5968492

http://www.w3.org/2001/XMLSchema#string